PRESS RELEASE

AI In Healthcare Use Case #30: Sweetch

Founded in 2014, Sweetch is a clinically validated mobile-health platform that utilizes artificial technology (AI) to significantly increase patients’ engagement and compliance with essential health promotion and chronic disease management recommendations through Just-in-Time Adaptive Intervention.

READ MORE July 16, 2019

Prof. David Nash Appointed to Sweetch Advisory Board

Sweetch Health, an Artificial Intelligence based platform for prediction, prevention and management of chronic diseases, has announced that healthcare pioneer Prof. David Nash, MD, MBA, Founding Dean Emeritus of the Jefferson College of Population Health has joined the Sweetch Advisory Board.

READ MORE June 27, 2019

IQVIA, EMIS Health partner to support GPs in England electronically ‘prescribe’ apps to patients

This morning, data science company IQVIA unveiled a partnership with EMIS Health, a Leeds-based primary care software provider, to enable GPs in England electronically ‘prescribe’ apps evaluated against NHS standards to patients.

READ MORE June 19, 2019

Sweetch: Promising Patients’ Compliance and Engagement with AI-based Behavioral Intelligence Engine

Artificial Intelligence (AI) is finding its way in various industries and uplifting their service capabilities to a great extent. The healthcare industry is no exception to this.

READ MORE May 5, 2019

AI Mobile Health App Sweetch Partners With WellSpan Health to Help Fight Diabetes

Sweetch, the first AI digital therapeutics solution that helps predict, prevent and improve outcomes among people with diabetes is partnering with integrated health care system WellSpan Health.

READ MORE October 31, 2018

Johns Hopkins study: coaching app Sweetch can increase weight loss, activity in prediabetes patients

A recent Johns Hopkins study found that prediabetic patients who used the interactive mobile coaching program Sweetch lost weight and increased physical activity. The study, published in JMIR, found that participant lost a mean 3.5 pounds and significantly improved weekly physical activity over the course of the three-month trial.

READ MORE March 8, 2018

Johns Hopkins Study Reveals Artificial Intelligence (AI)-Driven Mobile App Sweetch Reduces Blood Sugar Levels in Early Stage Diabetes Patients

Sweetch, the mobile-health app that helps prevent and improve outcomes in diabetes by encouraging long-term behavioral change, today revealed the outcomes of its clinical trial conducted at Johns Hopkins University. Directed by the university’s Division of Endocrinology, Diabetes, & Metabolism, the study shows that using Sweetch significantly lowered A1C levels, a diabetes biomarker for blood […]

READ MORE March 8, 2018

Sweetch’s AI-driven app claims to reduce risk of developing diabetes

While the world tries to decide whether artificial intelligence is here to help us or hurt us, AI is quietly infiltrating our daily lives — from streaming recommendations to image recognition. And in health technology, AI is making a real difference to people across the world, saving lives in a multitude of ways.

READ MORE March 6, 2018

A Novel Approach for Fully Automated, Personalized Health Coaching for Adults with Prediabetes: Pilot Clinical Trial

Background: Prediabetes is a high-risk state for the future development of type 2 diabetes, which may be prevented through physical activity (PA), adherence to a healthy diet, and weight loss. Mobile health (mHealth) technology is a practical and cost-effective method of delivering diabetes prevention programs in a real-world setting.

READ MORE February 27, 2018

Sweetch Develops AI Platform That Predicts Individual’s Risk For Developing A Metabolic Syndrome Related Disease

Sweetch is an Artificial Intelligence-based platform aimed at reducing the risk and improving the outcomes of Metabolic Syndrome diseases – Diabetes, Pre-Diabetes, Hypertension, Pre-Hypertension, Obesity, and Hyperlipidemia. Below is our interview with Dana Chanan CEO at Sweetch: […]

READ MORE January 25, 2018